Allay Therapeutics
Manufacturing · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
2720 Zanker Rd, San Jose, California, 95...Phone Number
(650) 514-6284Website
www.allaytx.comRevenue
$10 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
2
1
1
1
1
1
About Allay Therapeutics
Allay Therapeutics is a San Jose, CA-based clinical-stage biotechnology company providing ultra-sustained analgesic products for post-surgical pain management and recuperationExplore more
Allay Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Allay Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Allay Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Allay Therapeutics had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Allay Therapeutics has new funding data
Earning: See what the market has to say on Allay Therapeutics recently announced quarterly report
Check if Allay Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Allay Therapeutics launches new products
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Allay Therapeutics
Check out if Allay Therapeutics is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to Allay Therapeutics
Compare insights from companies similar to Allay Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Allay Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Allay Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Allay Therapeutics.
Allay Therapeutics financials insights
Gather financial insights about Allay Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2017
Series A
$7M
2019
Series B
$25M
2021
Series C
$60M
2025
Series D
$57.5M
Allay Therapeutics Tech Stack
A closer look at the technologies used by Allay Therapeutics
Most Recent Scoops
Funding
Funding
Executive Move
Executive Moves, Board of Directors
Partnership
Partnership, Research & Development, Product Management, Intellectual Property, Sales Development
Executive Move
Board of Directors
Allay Therapeutics News & Media
Allay Therapeutics Announces $57.5M Series D Financing and Venture Debt Line ... - Business Wire
Allay Therapeutics, a clinical-stage biotechnology company pioneering ultra-sustained analgesic products to transform post-surgical pain management and recup...Allay Therapeutics Announces Expansion of Clinical and Scientific Advisory Boards to Support the Company’s Mission to Transform Post-Surgical Pain Management
SAN JOSE, Calif.--(BUSINESS WIRE)--Allay Therapeutics, a clinical-stage biotechnology company pioneering ultra-sustained analgesic products to transform post-surgical pain management and recuperation, today announced the expansion of its Clinical and Scientific Advisory Boards to support the company as it advances its clinical candidate ATX101 and develops its pipeline to support patients, physicians and payors with novel, extended-duration post-surgical pain management solutions. With the expaAllay Therapeutics Announces FDA Acceptance of Investigational New Drug (IND) Application to Initiate Pivotal Phase 2B Trial of ATX101 for the Treatment of Post-Surgical Pain Following Total Knee Replacement Surgery
SAN JOSE, Calif.--(BUSINESS WIRE)--Allay Therapeutics, a clinical-stage biotechnology company pioneering ultra-sustained analgesic products to transform post-surgical pain management and recuperation, today announced plans to proceed to a Phase 2b registration trial of its lead investigational product ATX101. The clinical trial builds on a strong foundation of clinical data from prior exploratory dose-ranging studies and is informed by recent discussions with the U.S. Food and Drug AdministratiAllay Therapeutics Announces Development and Commercialization Agreement with Maruishi Pharmaceutical for Ultra-Sustained Pain Therapeutics in Japan
SAN JOSE, Calif. & OSAKA, Japan--(BUSINESS WIRE)--Allay Therapeutics, Inc. (Allay) today announced that they have entered into a license agreement with Maruishi Pharmaceutical Co., Ltd. (Maruishi), providing Maruishi with exclusive rights to develop and commercialize Allay’s lead investigational drug candidate, ATX101, and other ultra-sustained analgesic implantable drug candidates for acute pain in Japan. ATX101 is a non-opioid, bupivacaine-based drug product designed to deliver continual, loc
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Allay Therapeutics
Sign Up For FreeTo access detailed company insights
Allay Therapeutics is a San Jose, CA-based clinical-stage biotechnology company providing ultra-sustained analgesic products for post-surgical pain management and recuperation... Read More
